Charles Schwab Investment Management Inc. Grows Stock Holdings in Axcelis Technologies, Inc. $ACLS

Key Points

• Charles Schwab Investment Management Inc. increased its stake in Axcelis Technologies by 4.3%, owning 386,007 shares worth $19.17 million as of the most recent reporting period.
• Several hedge funds, including Reinhart Partners LLC and Voloridge Investment Management LLC, also significantly increased their holdings in Axcelis Technologies during the first quarter, indicating strong institutional interest.
• Axcelis Technologies reported earnings of $1.13 per share, exceeding expectations, but its revenue was down 24.2% year-over-year, with a market capitalization of $2.55 billion.

Charles Schwab Investment Management Inc. increased its position in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 4.3% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 386,007 shares of the semiconductor company's stock after acquiring an additional 16,071 shares during the period. Charles Schwab Investment Management Inc. owned about 1.20% of Axcelis Technologies worth $19,173,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ACLS. Raymond James Financial Inc. purchased a new position in shares of Axcelis Technologies in the fourth quarter worth $397,000. Barclays PLC raised its position in Axcelis Technologies by 7.9% in the 4th quarter. Barclays PLC now owns 73,471 shares of the semiconductor company's stock worth $5,132,000 after buying an additional 5,360 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Axcelis Technologies by 11.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 724,585 shares of the semiconductor company's stock worth $50,628,000 after buying an additional 71,631 shares during the last quarter. MetLife Investment Management LLC lifted its stake in Axcelis Technologies by 5.8% during the 4th quarter. MetLife Investment Management LLC now owns 19,885 shares of the semiconductor company's stock valued at $1,389,000 after acquiring an additional 1,095 shares during the period. Finally, Nebula Research & Development LLC purchased a new stake in shares of Axcelis Technologies during the 4th quarter valued at about $560,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.

Axcelis Technologies Stock Performance

Shares of NASDAQ ACLS traded down $0.91 during trading on Monday, hitting $80.38. The company had a trading volume of 293,205 shares, compared to its average volume of 587,617. Axcelis Technologies, Inc. has a 12 month low of $40.40 and a 12 month high of $113.75. The company has a debt-to-equity ratio of 0.04, a quick ratio of 4.26 and a current ratio of 6.01. The firm has a market capitalization of $2.53 billion, a P/E ratio of 16.07 and a beta of 1.58. The stock has a 50 day simple moving average of $74.05 and a 200 day simple moving average of $62.43.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last released its earnings results on Tuesday, August 5th. The semiconductor company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.73 by $0.40. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. The company had revenue of $194.54 million during the quarter, compared to analyst estimates of $185.15 million. During the same period in the prior year, the firm posted $1.55 EPS. The firm's quarterly revenue was down 24.2% compared to the same quarter last year. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. As a group, analysts anticipate that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current year.

Analysts Set New Price Targets

ACLS has been the subject of several research reports. B. Riley boosted their price objective on shares of Axcelis Technologies from $58.00 to $75.00 and gave the company a "neutral" rating in a report on Wednesday, June 18th. DA Davidson boosted their target price on shares of Axcelis Technologies from $75.00 to $90.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $90.00.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.